Where the New Hospice Metrics Are Won: The Pharmacy Relationship

Over the next month, most of what a hospice hears about the new service and spending variation index will come down to one instruction: tighten your documentation. That advice is not wrong. It also will not change the part of the score that is decided somewhere most hospice leaders are not looking: at a pharmacy counter.

What the score is actually watching

The SSVI runs from 0 to 16, and half of it, eight points, measures non-hospice spending: the Medicare money spent on your patients that is outside the hospice benefit while they are on your census. Documentation matters for defending that number, but it does not lower it. The score is built from dollars, and the dollars only move when what gets billed, and to whom, changes.

One of the pieces of that you can influence is prescriptions. When a drug that should have been covered under the hospice benefit gets billed to Medicare Part D instead, it lands in your non-hospice spending. The decision to bill it there is not made in your building. It is made at a pharmacy, often after hours, by someone who does not work for you.

Four ways the wrong payer gets picked

Picture the same drug going out four different ways.

A patient lives in a nursing facility, and a physician there writes a prescription that the facility's pharmacy fills. That pharmacy often does not know the patient is on hospice at all, let alone which medications the hospice has taken responsibility for. So it bills the prescription the way it bills everything else.

A local pharmacy that has filled hospice scripts for years starts pulling back. The prior authorizations pile up, the reimbursement on a hospice claim is thin, and at some point the math stops working. Fewer pharmacies willing to fill for your patients means more prescriptions routed to whoever will, on whatever terms they run.

A claim rejects at the counter. The patient is standing there, or the family is waiting on the phone, and the fastest way to get the medication into their hands is to run it through the patient's Part D plan and move on. For a younger or pediatric patient it might be Medicaid or a private plan instead. Either way, the drug is now billed outside your benefit.

Lastly, a prescription goes to a mail-order pharmacy that never got word the patient is on hospice, whether because the election has not caught up in the plan's system yet or because that pharmacy was never in the hospice's loop to begin with. It fills and bills the way it does for everyone else and no one at the hospice sees it happen.

Each one ends the same way. A drug that should have been covered by the hospice gets billed somewhere else, and it lands on a number that reads back as yours.

Where the hospice has control

None of that means the hospice is powerless and none of it is about gaming a number. Every one of those four outcomes runs through something the hospice shapes: which pharmacies it works with, how its formulary is built, and whether the coverage answer reaches the counter before the claim does.

The lever is prevention. When a prescription reaches the pharmacy with its coverage already confirmed, it does not reject, so the pharmacy never has to decide where else to send it. Preventing that rejection does two things at once. It takes work off the pharmacy, which is how a hospice stays a pharmacy worth filling for, and it makes the accurate bill the path of least resistance instead of the harder path a busy counter skips.

This is the piece the documentation conversation misses. Better records help you explain your non-hospice spending after it has happened. Preventing the wrong bill is what lowers it.

What this looks like with MerlinRx

MerlinRx is built to answer the coverage question before a prescription leaves the workflow, so it reaches the pharmacy in a state the pharmacy can fill without a fight. When something genuinely needs a prior authorization, both sides can see it and follow up, rather than discovering it at the counter. The pharmacy's load gets lighter, and when your model depends on local pharmacies, that matters a great deal.

The effect shows up where it matters: the claim processes and the pharmacy is able to fill the medication and move on to the next. The drug is billed where it belongs and the number that gets read as yours reflects what actually happened.

Read the score for what it is

The pharmacy is not a fax number at the end of your workflow. In a hospice built on local relationships, it is infrastructure, and the new score is partly a downstream reading of how well your information reaches it.

That is the useful way to read the SSVI. Not as a documentation project, but as a question about whether the right answer gets to the counter before the claim does. Strengthen the relationship, prevent the rejection, and accurate billing follows on its own. The score is just reading that back to you.